Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

SPPCP Virtual Conference April 9, 2019


The Society of Pain and Palliative Care Pharmacists is pleased to announce its 2019 Virtual Conference on Pain and Palliative Care to be held via web-conferencing on April 9th, 2019 from  1pm to 5pm EST.  This timely web-based conference will provide the pain and palliative care clinician with cutting edge tools that are readibly applicable to practice.  Up to 4.0 contact hours of continuing education credits will be available for pharmacists.
 
All times listed are Eastern Time 
 
 Link to Join the Virtual Conference
 
 
For speakers:
Dial by your location
        +1 646 558 8656 US (New York)
        +1 669 900 6833 US (San Jose)
Meeting ID: 334 218 243
 
 
 

Date: Apr 9, 2019 01:00 PM - 05:00 PM

Fee

$0.00

CE Hours

3.50

CE Units

0.350

Registration closes on Apr 19, 2019 12:45 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict.  The existence of relationships does not necessarily imply bias or lessen the value of the activity.  All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers.  The relevant commercial financial relationships or affiliations must have occured over the past 12 months.

 
Accreditation Council for Pharmacy Education
Southern Illinois University Edwardsville School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  
 
 
 
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of completing the activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity.   Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
 
 
 

 

Co-Sponsor(s)

Society of Pain and Palliative Care Pharmacists

Requirements for CE Credit

All Times listed are Eastern Time

 

 

Registration closes on Apr 19, 2019 at 12:45 PM

Registration Closed  

Objectives

  • Compare different buprenorphine products used for substance use disorder and pain
  • Outline restrictions associated with buprenorphine products to assure compliance to all regulations provided by the Drug Enforcement Agency (DEA) and Substance Abuse and Mental Health Services Administration (SAMSHA).
  • Explain initiation process of buprenorphine in the Emergency Department for patients seeking medication assisted treatment for SUD

Speaker(s)/Author(s)

Maria C. Foy picture

Maria C. Foy, PharmD, BCPS, CPE
Patient Care Coordinator, Palliative Care, Abingdon Memorial Hospital


Brief Bio : Dr. Foy earned her PharmD from University of the Sciences in Philadelphia. She is a certified pain educator. She is currently the Patient Care Coordinator, Palliative Care at Abingdon Memorial Hospital in Abingdon, Pa.
Disclosure : Maria C. Foy has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-19-010-L01-P
Date: 04/09/19
Time: 01:05 PM - 01:35 PM

CE Hours

0.50

Location

Online
Registration Closed  

Registration Closed  

Managing pain in palliative care patients who have a history of addiction or substance abuse is challenging. Buprenorphine is a unique opioid that may provide pain relief while limiting abuse potential.
 
Participants will be more confident in using buprenorphine for pain management in a palliative care setting after discussing safety and efficacy considerations of continuing versus discontinuing buprenorphine for acute pain management, reviewing data regarding the use of buprenorphine for cancer pain, and considering the role of buprenorphine in palliative care for cancer pain in patients with a history of substance use disorder. 

Objectives

  • Discuss safety and efficacy considerations of continuing versus discontinuing buprenorphine for acute pain management
  • Restate data regarding buprenorphine use for cancer pain
  • Explain buprenorphine’s role in palliative care for patients with cancer pain and a history of substance use disorder

Speaker(s)/Author(s)

Gary Houchard picture

Gary Houchard
Ohio State University Wexner Medical Center


Brief Bio : Gary Houchard is a Clinical Pharmacy Specialist in Palliative Medicine at The Ohio State University Wexner Medical Center – James Cancer Hospital. He rotates between the inpatient palliative consult service and the benign hematology service. Gary received his PharmD from the University of Michigan in Ann Arbor. He completed a PGY-1 pharmacy practice residency at Sarasota Memorial Hospital in Sarasota, Florida, followed by a PGY-2 residency in pain management and palliative care at the Ohio State University.
Maureen Saphire picture

Maureen Saphire, PharmD, BCPS, BCACP
Specialty Practice Pharmacist, Ohio State University Wexner Medical Center


Brief Bio : Dr. Saphire earned her PhamD. degree from Ohio Northern University Raabe College of Pharmacy. She was a PGY-1 Ambulatory care Pharmacy Practice resident at the The Ohio State university College of Pharmacy. She is currently a Specialty Practice Pharmacist, Palliative Medicine at the Ohio State University Wexner Medical Center. She is also the Residency Program Director for the Pain and Palliative Care Residency Program.
Disclosure : Maureen Saphire has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-19-011-L01-P
Date: 04/09/19
Time: 01:40 PM - 02:40 PM

CE Hours

1.00

Location

Online
Registration Closed  

Registration Closed  

In 2015, 15% of the US population was made up of individuals ≥65 years and older. This number is expected to climb to 22-25% by 2050. This population is more vulnerable to disease, more likely to experience chronic pain, and subsequently receive opioids. Opioid

overdose-related mortality (OORM) from prescription opioids has increased dramatically in the US, especially among individuals ≥65 years old. As the incidence of opioid use disorder (OUD) and subsequent overdose increases, this poses a treatment challenge in the geriatric population. Many practitioners are not trained in caring for older adults with comorbid OUD and chronic pain and would benefit from additional education and training, given our changing population.

 

This session will review appropriate treatment strategies when treating comorbid OUD and chronic pain, with a focus on age-related special considerations.

Objectives

  • Review epidemiology of opioid use disorder (OUD) in older adults
  • Recognize risk factors predisposing patients to OUD, signs/symptoms of OUD, and appropriate pharmacologic strategies to treat OUD in older adults
  • Review epidemiology of comorbid OUD and chronic pain in older adults
  • Apply special considerations when treating OUD in the setting of chronic pain among older adults with chronic pain

Speaker(s)/Author(s)

Alyssa M. Peckham  picture

Alyssa M. Peckham , PharmD, BCPP
Assistant Professor, Psychiatry and Substance Abuse Disorders, Northeastern University Bove College of Health Sci


Brief Bio : Dr. Peckham earned her PharmD. At the University of Rhode Island. She attained both her PGY-1 (Pharmacy Practice) and PGY-2 (Psychiatry Pharmacy) Residencies from the Veterans Administration Connecticut Healthcare System.
Disclosure : Alyssa Peckham has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Macayla Landi picture

Macayla Landi, PharmD, BCPS, BCGP
Assistant Clinical Professor, Northeastern University Bouve College of Health Sc


Brief Bio : Dr. Landi earned her PharmD Degree from the University of Rhode Island. She completed a PGY-1 Pharmacy Practice Residency at the Veteran Affairs Connecticut Healthcare System. Her PGY-2 Residency Geriatric Pharmacy was attained at the same institution.
Disclosure : Macayla Landi has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-19-009-L01-P
Date: 04/09/19
Time: 02:45 PM - 03:45 PM

CE Hours

1.00

Location

Virtual
Registration Closed  

Registration Closed  

Herbal products and supplements are commonly used by patients enrolled in palliative care, with many patients expressing preference for natural treatments over prescription drugs. Pharmacists may be asked to make recommendations about natural treatments despite limited education on this subject during pharmacy training. This program will help pharmacists better understand the literature for use of a variety of natural treatments and make well informed recommendations to their patients and providers.
 
The educational goal of this activity is to critically assess the evidence for use of common herbal or natural supplements in palliative care and allow the participant to make an informed decision for or against use in their patients. Participants will take away clinical pearls to apply to their practice when a natural approach is sought.

Objectives

  • Evaluate the evidence for use of select supplements for symptom management in palliative care: alpha lipoic acid, American ginseng, D-mannose, ginger, peppermint oil and cannabis (CBD vs. THC).
  • Identify key resources and databases to assist in evaluation of natural medicines

Speaker(s)/Author(s)

Crystal A. Wright picture

Crystal A. Wright, PharmD, BCPS, BCACP
Geriatrics and Palliative Care Clinical Pharmacy Specialist, Kaiser Permanente


Brief Bio : Dr. Crystal A. Wright earned her PharmD from Mercer University College of Pharmacy. She completed a PGY-! Managed care Pharmacy Residency at Kaiser Permanente and a PGY-2 Ambulatory Care Clinical Pharmacy Residency at the same institution. She also completed an ASHP Foundation Advanced Pain and Palliative Care Traineeship at the University of Maryland School of Pharmacy.
Disclosure : Crystal A. Wright has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Melissa A. Berman, PharmD, BCACP
Geriatric & Palliative Care Clinical Pharmacy Specialist, Kaiser Permanente


Brief Bio : Dr. Melissa A. Berman earned her PharmD from the University of Florida College of Pharmacy. She completed a PGY-1 Pharmacy Practice Residency at the North Florida/South Georgia Veterans Health System. Her PGY2 Ambulatory care Residency was completed at Kaiser Permanente. Dr. Berman is currently a Geriatric and Palliative Care Clinical Pharmacy Specialist at Kaiser Permanente of Georgia.
Disclosure : Melissa A. Berman has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-19-008-L01-P
Date: 04/09/19
Time: 03:50 PM - 04:20 PM

CE Hours

0.50

Location

Virtual
Registration Closed  

Registration Closed  

Many providers would like to provide this option to patients who are experiencing extreme pain as a result of their disease process. Palliative sedation is an intervention of last resort when a patient experiences severe pain or other distressing clinical symptoms that do not respond to symptom management and to uphold the patient’s wishes.
 
This presentation is designed to help pharmacy practitioners better understand how to manage severe and refractory symptoms at end-of-life by inducing a decreased level of consciousness. 

Objectives

  • Explain the ethical justification for palliative sedation
  • Evaluate and effectively recommend various medication options with appropriate dosing and administration for use in palliative sedation
  • Illustrate advantages and disadvantages of specific medications with emphasis on adverse effects and cost.

Speaker(s)/Author(s)

Alifia Waliji-Banglawala picture

Alifia Waliji-Banglawala, PharmD
Director of Pharmacy Services, Care Dimensions


Brief Bio : Dr. Waliji-Banglawala earned her PharmD degree from the University of Florida. She completed a Pharmacy Practice Residency at Tampa General Hospital in Tampa Florida. Dr. Waliji-Banglawala is currently the Director of Pharmacy Services at Care Dimensions in Danvers/Waltham, MA. She is a member of the ethics committee at Care Dimensions.
Disclosure : Alifia Waliji-Banglawala has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-9999-19-007-L01-P
Date: 04/09/19
Time: 04:25 PM - 04:55 PM

CE Hours

0.50

Location

Virtual
Registration Closed